. Transplantation experiments permit studies of individual separable cell subpopulations generated during carcinogenesis as well as of the behaviour of carcinogen-altered cells in an in vivo environment not exposed to carcinogens (Hanigan & Pitot, 1985) .
Cells isolated from the livers of carcinogen-treated rats have been shown to proliferate after transplantation to the spleen (Finkelstein et al., 1983) or liver (Laishes & Rolfe, 1980; Hanigan & Pitot, 1985; Saeter et al., 1987) of syngeneic hosts. The transplanted cells first form focal proliferations, then neoplastic nodules and hepatocellular carcinomas which are morphologically and biochemically similar to those of primary experimental hepatocarcinogenesis (Laishes & Rolfe, 1980; Hanigan & Pitot, 1985; Saeter et al., 1987; Roomi et al., 1985; Hunt et al., 1982) . Transplantation experiments permit studies of individual separable cell subpopulations generated during carcinogenesis as well as of the behaviour of carcinogen-altered cells in an in vivo environment not exposed to carcinogens (Hanigan & Pitot, 1985) .
One interesting feature of carcinogen-altered hepatocytes is their change in DNA content. We have previously reported a significant increase in the fraction of diploid hepatocytes during early stages of liver carcinogenesis induced by treatment with diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) (Schwarze et al., 1984; Seglen et al., 1988b) . Moreover, neoplastic nodules and hepatocellular carcinomas generated in this model have been shown to contain 70-90% diploid cells, as compared to only 10% in the normal, polyploid liver Saeter et al., 1988a) . Similar findings have been reported in other models of rat liver carcinogenesis (Neal et al., 1976; Irving et al., 1977; Styles et al., 1985; Deleener et al., 1987) , indicating that replacement of normal polyploidising growth by diploid divisional proliferation may be a fundamental feature of chemical hepatocarcinogenesis.
To further investigate the stability and importance of this phenotypic alteration we have studied the DNA content of isolated nuclei from neoplastic nodules and hepatocellular carcinomas arising in host liver after intraportal injection of hepatocytes from syngeneic carcinogen-treated donor rats. Tumour ploidies have been compared with hepatocytic ploidy distributions in the surrounding host liver. Furthermore, the relative amounts of diploid and polyploid donor hepatocytes were varied over a wide range by means of centrifugal elutriation, in order to study the effects of such manipulations upon the ploidy patterns of resultant host liver tumours.
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Finally, we have characterised our transplantation model in terms of degree of donor cell retention in host liver and cell dose versus tumour yield, and studied the effect of secondary promotion in the host with dietary phenobarbitone (PB).
Materials and methods
Donor animal treatment and isolation of donor hepatocytes Four-week old male rats (70g) of the inbred Wistar Kyoto strain were subjected to partial hepatectomy (PH) and 24h later injected intraperitoneally with DEN (50mgkg-1). Following one week's rest on basal diet, the animals were fed a semi-synthetic diet (Bio-Serv Inc., Frenchtown, NJ, USA) containing 0.02% AAF for 4 weeks, then returned to basal diet. This initiation-promotion regimen produces multiple neoplastic nodules from 8 weeks after start of treatment and hepatocellular carcinomas from 4 months onwards . At 6 or 8 weeks after start of treatment donor hepatocytes were isolated by two-step collagenase liver perfusion and the cells purified by differential centrifugation as described previously (Seglen, 1976) . Some donor cell suspensions from carcinogen-treated animals were subjected to centrifugal elutriation for the purpose of altering the relative amounts of diploid and polyploid donor hepatocytes before injection into the host liver. The viability of donor hepatocytes was in general in excess of 90% as determined by trypan blue exclusion.
For control experiments and studies of donor cell retention in recipient liver, donor hepatocytes were obtained by collagenase perfusion of livers from normal, untreated 10-week-old rats.
Measurement of DNA content of donor hepatocytes Intact donor hepatocytes were stained with mithramycin (100,ugml-1 in 25% ethanol) and their DNA content measured in a laboratory-built flow cytometer as previously described (Schwarze et al., 1984) . On average 10,000 cells were analysed in each sample. Non-parenchymal liver cells were prepared separately (Seglen, 1976 (Seglen, , 1979 and used as an external diploid standard.
Intraportal transplantation procedure and host treatment Our method is similar to the one described by Hanigan & Pitot (1985) . Under halothane or ketaline/xylazine anaesthesia, male inbred Wistar Kyoto rats (170-200g) were subjected to PH. Immediately afterwards, donor hepatocytes suspended in 1.0ml of cold suspension buffer (Seglen, 1976) were injected slowly (45 s) into the portal circulation through an ileal tributary vein which was subsequently tied off. For studies of ploidy distributions in recipient liver tumours, 1.0 or 3.0 x 106 viable donor hepatocytes were injected. For studies of the influence of donor cell number on tumorigenesis, the cell dose range was 0.01-3.0 x 106 viable donor cells.
Following the transplantation procedure, recipient animals were fed either basal diet throughout or the semi-synthetic diet containing 0.04% phenobarbitone (PB) until the time of killing or for a maximum period of 4 months.
Retention of donor cells in recipient liver Donor hepatocytes were labelled in vitro with 5"Cr by incubating 500 Ml aliquots of cell suspension (5.0 x 106 cells) with 5p1 sodium chromate Ci) in 0.9% NaCl in a shaking water bath at 37°C for 3min. This incubation time was chosen after preceding experiments showing that, at 37°C, no additional labelling was obtained by incubating cells for longer periods (Figure la) . Furthermore, the labelling obtained was of a very stable nature, with no significant spontaneous release of 51Cr during in vitro incubation at 37°C for 2h (Figure lb) , during which time there was only a 10% drop in cell viability (data not shown). In these experiments, 400 p aliquots of cell suspension were incubated with 20 pCi of 5"Cr and subsequent cell-bound radioactivity was determined as described below.
Following incubation, the cells were washed twi¢e and resuspended in the suspension buffer containing pyruvate (2.6mgml-1) followed by adjustment of the final cell concentration to 1.0 x 106 viable cells ml -1. Intraportal injection of 1 ml of cell suspension was then performed as described above. Recipient animals were killed by exsanguination through the large retroperitoneal vessels at various time points from immediately after injection (zero time point) to one week after transplantation. The livers were removed, the total liver radioactivity was measured in a gamma-counter and expressed as per cent of the amount of injected cell-bound radioactivity. The latter was estimated by gamma counting of the cell pellet obtained after centrifugation of 1 ml of labelled donor cell suspension through a 0.5 ml 8% metrizamide/8% sucrose cushion (Seglen, 1976) . For the study of cell retention as a function of cell dose, recipients were injected with 0.5-10.0 x 106 5tCr-labelled hepatocytes and all recipients killed 48 h later. In one of the experiments the donor hepatocytes were prelabelled in vivo with tritiated thymidine by injecting the donor animals with 1.0 ml 3H-thymidine solution (2.0pCi) into the penile vein 18.5 h after PH. Donor hepatocytes were isolated 24h after thymidine injection, double-labelled with 51Cr in vitro and transplanted to recipients as described above. Following sacrifice of the recipients and measurement of 1Cr-derived radioactivity, the livers were homogenised in 0.25 M sucrose and nuclei were isolated by centrifugation through 2.3 M sucrose in a Beckman SWTi 65 rotor at 36,000 r.p.m. for 30 min (Blobel & Potter, 1966) . The isolated nuclei were dissolved in 0.1 N NaOH, 0.4% deoxycholic acid and their radioactivity measured in a liquid scintillation counter. The fraction of cells retained in the recipient liver was then estimated by relating total recipient liver nuclear radioactivity to the nuclear radioactivity measured in the donor cell suspension. Isolated nuclei displayed no 5ICr activity.
Isolation of host liver tumours and nuclear DNA measurements At various times after transplantation of preneoplastic hepatocytes, collagenase perfusions of the host livers were performed. Neoplastic nodules and hepatocellular carcinomas are not dissociated by such portal perfusion due to their predominantly arterial blood supply (Conway et al., 1985) and may therefore be removed intact from the initial cell suspension by filtration through a 250 pm nylon mesh and subsequently quantified as described elsewhere .
One part of each tumour was used for histological examination after staining of 100pm sections with Haematoxylin and Eosin and classified as neoplastic nodules or hepatocellular carcinomas according to Squire & Levitt (1975) . From another part of the neoplasm, isolated nuclei were prepared by the trypsin-detergent method of Vindel0v et al. (1983) and stained with propidium iodide (17 pgml-1 in phosphate-buffered saline). The DNA content of isolated nuclei was then determined in the flow cytometer (Schwarze et al., 1984) , using nuclei from human splenic lymphocytes and chicken erythrocytes for standardisation of diploid DNA content. On average 10,000 nuclei were analysed from each tumour.
Purified suspensions of hepatocytes from normal livers (2-4 months after PH), from control hosts (PH+injection of normal hepatocytes) and from host liver surrounding the neoplasms were prepared by portal collagenase perfusion (Seglen, 1976) and DNA content of isolated nuclei was determined as described above. The procedure for purification of hepatocytes employing low speed differential centrifugation effectively eliminates contamination of the sample by diploid non-parenchymal cells (comprising approximately 40% of all cells), securing an accurate determination of purely hepatocellular DNA content (Seglen, 1976; Schwarze & Seglen, 1985; Schwarze et al., 1986) . Nodules and carcinomas induced in our rat liver model contain only insignificant numbers of non-parenchymal cells ( Figure 3 and Saeter et al., 1988a) . Therefore, preparation of isolated nuclei by mechanical distruption of the neoplasm yields a good material for specific DNA analysis of neoplastic nuclei, as previously demonstrated .
Ploidy nomenclature In our analysis of histograms obtained by flow cytometric DNA measurements of isolated nuclei, diploid nuclei are those situated in the diploid peak or in the area between the diploid and tetraploid peaks (diploid S-phase nuclei). For two reasons, ploidy studies of isolated nuclei will underestimate the difference in polyploidisation between tumours and surrounding livers. Firstly, the 'tetraploid' peak will be made up of both diploid G2-phase nuclei and true tetraploid GI-phase nuclei. Single parameter flow cytometry is unable to distinguish between these two classes. In our analysis, all nuclei situated in the 'tetraploid' peak are counted as GI tetraploid, thus somewhat underestimating the fraction of nuclei belonging to the diploid divisional cycle. Secondly, in normal liver, only approximately half of the diploid nuclei stem from mononucleated diploid cells, the rest being contributed by binucleated tetraploid cells (containing two diploid nuclei) Saeter et al., 1988b) . Thus, in normal liver, the fraction of diploid hepatocytes will be overestimated if represented by the fraction of isolated diploid nuclei. However, as single cell suspensions are difficult to prepare from tumours, isolated nuclei were prepared from both tumours and surrounding or normal livers to allow ploidy comparisons. Indeed, for the purpose of demonstrating the altered tendency for polyploidisation taking place during hepatocarcinogenesis, analysis of isolated nuclei suffices, as will be demonstrated in the present work.
Ploidy analysis of donor hepatocytes was performed on intact whole cells. This measurement provides true values for the fraction of diploid mononucleated donor cells (apart from a slight underestimation due to two-cell aggregate formation).
Identifiable nuclear subpopulations deviating in DNA content from the diploid, tetraploid or octoploid areas were considered to have aneuploid DNA content.
Histochemical studies Frozen sections were made from carcinomas and from biopsies taken from the distal part of the right anterior lobes of tumour-bearing and normal host livers prior to perfusion and were subsequently stained for gamma-glutamyl transpeptidase (GGT) activity according to Rutenburg et al. (1969) . GGT analysis was also done on donor cell suspensions from both carcinogen-treated and normal livers.
Reagents
Diethylnitrosamine and 2-acetylaminofluorene were obtained from Sigma Chemical Co. (St Louis, MO, USA). Mithramycin was from Pfizer Ltd (Sandwich, UK) and propidium iodide from Calbiochem AG (Lucerne, Switzerland). "Cr (as sodium chromate) and 3H-thymidine were purchased from Amersham International (Amersham, UK).
Results
Retention of donor cells in recipient liver Figure 2 shows the fraction of donor cell radioactivity remaining in recipient liver as a function of time. The figure indicates that there is a rapid disappearance of injected cells within the first hour followed by a slow decline during the next 24 h. Subsequently the curves level out and remain stable, indicating that in the order of 20% of the injected hepatocytes are finally retained by the recipient liver. Separate experiments utilising centrifugal elutriation of donor cell suspensions before labelling and injection showed that small (diploid) hepatocytes were retained to the same degree as larger (tetraploid and octoploid) cells (data not shown). Table I shows that the percentage of cells remaining 48h after intraportal injection was the same at all cell concentrations, i.e. the number of cells retained was proportional to the number of cells injected. After injection of hepatocytes from carcinogen-treated rats, the number of nodules and carcinomas appearing in the host liver was likewise roughly proportional to the number of cells injected (Table II) . hepatocellular carcinomas measuring up to several cm in diameter. Table III shows the promotional effect of PB in this transplantation model. Three months after cell injection all hosts fed PB had tumours, either both nodules and carcinomas (60%) or nodules only (40%). In contrast, approximately 60% of the hosts fed normal diet were without tumours. The remaining 40% had nodules only; no tumours at this time point were classified as carcinomas. In addition there was a tendency for the livers of PB-fed recipients to contain more nodules per nodule-positive liver than the control recipients (5.0 + 1.7 versus 1.3+0.3; P> 0.05, t test). At 8-9 months several hosts had carcinomas even without previous treatment with PB. Apparently PB is not necessary for carcinoma formation in this transplantation model, but it accelerates the process considerably, thus acting as a secondary promoter.
No animal injected with normal hepatocytes developed liver tumours at any time point (Table III) .
DNA content of donor and host hepatocytes and of tumours arising in host liver Ploidy distributions were determined by flow cytometry of nuclei isolated from 74 neoplastic nodules, 78 hepatocellular carcinomas and suspensions of surrounding hepatocytes, all isolated from host liver 2-9 months after intraportal injection of hepatocytes from preneoplastic carcinogentreated liver. In addition, nuclear ploidy determinations were performed on samples from nine normal livers. Figure 4 shows typical frequency histograms of the DNA content of nuclei isolated from a nodule, a carcinoma and from surrounding host hepatocytes. The increase in the relative amount of diploid nuclei in the tumours as compared to the surrounding (mostly tetraploid) host liver is evident. Thus, in nodules and carcinomas, 70-90% of the nuclei were in general diploid. In normal liver and in liver surrounding host tumours, only 20% of hepatocytic nuclei were diploid (Table  IV) . More than half of the tumours contained in excess of 80% diploid nuclei and all tumours were more diploid than any of the suspensions of surrounding host hepatocytes ( Figure 5 ). Carcinomas isolated from hosts fed normal diet contained an even higher fraction of diploid nuclei than carcinomas isolated from hosts fed PB (Table IV) . Too few nodules were available from host fed normal diet to assess the effect of PB on nodule ploidy. No nodules displayed aneuploid DNA peaks. Like in our model of primary experimental hepatocarcinogenesis , aneuploid tumours were rarely found in the transplantation model despite good peak re- Hepatocytes from neoplastic donor livers were isolated 6-8 weeks after initiation of carcinogen treatment (PH + DEN + AAF) and normal donor cells from 12-week-old untreated rats. Host rats received PH only or PH + PB. The number of tumour-bearing hosts is given as the fraction of the total number of animals in that group; aThe majority of rats receiving preneoplastic cells + PB had to be killed after 5-6 months due to debilitating tumour burden, whereas hosts fed normal diet were killed after 8-9 months. solution with a mean coefficient of variation below 4.5%. However, six hepatocellular carcinomas (8%) were found to contain small anaeuploid cell populations in the hyperdiploid, hypotetraploid or hypertetraploid region (Figure 6 ). These tumours were nevertheless predominantly diploid, the aneuploid subpopulations comprising only 10-15% of all nuclei. No correlation was found between the appearance of aneuploidy and tumour size, time of isolation or host treatment with PB. In some experiments, additional recipients were given suspensions that were enriched with or derprived of diploid donor hepatocytes by means of centrifugal elutriation . Figure 7 shows that regardless of the relative content of diploid cells in the donor cell suspension, resulting host liver nodules and carcinomas were always predominantly diploid.
GGT-expression in tumours and host liver All 18 host hepatocellular carcinomas tested displayed hyperexpression of GGT in large areas of the tumour tissue. Four out of five biopsies from surrounding liver showed focal proliferations of positive hepatocytes, presumably derived from GGT-hyperexpressive donor cells. This is supported by the finding that livers of carcinogen-treated donor rats contained 18.9 + 3.0% GGT-positive hepatocytes (n = 12), as compared to no GGT-positive hepatocytes in control rats of the same age (n = 4). Biopsies from five control host livers transplanted with normal cells only displayed positive staining in a very few scattered hepatocytes and in bile canalicular cells.
Discussion
Tumours arising in host liver after intrahepatic transplantation of carcinogen-altered hepatocytes are presumed to be derived from proliferation and progression of donor cells (Laishes & Rolfe, 1980; Hanigan & Pitot, 1985) . In the presently described model as many as 20% of the injected hepatocytes are retained by the recipient liver in The 51Cr label used in our experiments functions as a cellular marker that is rapidly lost and not reutilised upon cellular lysis (Zawydiwski & Duncan, 1978) ; retention of 51Cr therefore reflects the retention of intact cells. The stability of the marker is illustrated by our results (Figure 1 ). 3H-Thymidine-labelled DNA is likewise only preserved by intact cells, indicating that the permanently retained radioactivity represents surviving donor hepatocytes. Weiss et al. (1983) found that a comparable fraction of labelled melanoma cells was retained in mouse liver following intraportal injection. The reasonably linear dose-response relationship observed between the number of cells injected, the number of cells retained and the number of tumours formed in the recipient liver indicates that transplanted cells are indeed the precursors of the tumours. This is supported by the fact that tumours were never observed in the hosts unless they received donor cells from DEN-initiated rats. Tumour formation was then accelerated by using PB as a secondary (host) promoter. PH+PB, in the absence of transplants or after transplantation of normal hepatocytes, produced no tumours. In primary carcinogenesis PB, which lacks initiating activity, similarly depends on the presence of initiated cells to promote tumour formation (Watanabe & Williams, 1978; Schulte-Hermann et al., 1982) . It should be pointed out, however, that donor hepatocytes from carcinogen-treated livers eventually produced tumours even without PB promotion. In contrast to this, Hanigan & Pitot (1985) reported PB to be essential for formation of focal changes and tumours in host liver, at least within the time span studied. This difference may be due to the different carcinogen regimens used for donor animal treatment and the different rat strains used.
Accepting that in the current model the host liver tumours arise from injected cells, it becomes possible to study the fate of phenotypic alterations in preneoplastic donor hepatocytes following their transfer to and proliferation in an environment not affected by carcinogens.
Experimental hepatocarcinogenesis utilising DEN as initiating agent and AAF as promoter involves a switch in hepatocellular proliferation from normal polyploidisation to a diploid-diploid divisonal growth pattern (Schwarze et al., 1984; Seglen et al., 1986; Saeter et al., 1988a) . Six to eight weeks after start of treatment (end of AAF promotion period and time point for preneoplastic donor cell isolation in this study), purified hepatocyte suspensions contain 40-60% diploid cells as opposed to 10-15% in untreated liver (Schwarze et al., 1984; Seglen et al., 1986; ). This is due to a block in polyploidisation imposed by AAF, which may be part of the mechanism of promotion of this agent Saeter et al., 1988b) . This new proliferation pattern is constitutively maintained in neoplastic nodules and in carcinomas which uniformly contain 70-90% diploid cells regardless of the time point of isolation ). The present study shows that following intraportal transplantation of preneoplastic hepatocytes generated in this model, resulting host liver nodules and carcinomas are similarly totally dominated by diploid nuclei. Non-parenchymal (diploid) cells were scarce in the tumours (Figure 3) , and do not significantly contribute to the diploid peak. Furthermore, binucleated (2 x 2 N) cells have been shown to make up only 6% of cells in carcinomas as compared to 20-30% in normal rat liver . Thus the vast majority of diploid nuclei in host nodules and carcinomas stem from mononucleated diploid hepatocytes. As previously mentioned, single parameter flow cytometric DNA measurements are unable to distinguish between diploid G2 and tetraploid GI nuclei. Thus, since more than half of the tumours contained 80-95% diploid nuclei (GI plus S-phase) whereas no tumours had in excess of 95%, a minimum of 5% are probably diploid G2 nuclei registered in the tetraploid peak. Truly tetraploid (G1) nuclei are therefore very scarce in tumours; indeed the virtual absence of tetraploid G2 nuclei (octoploid peak) testifies to the insignificance of tetraploid proliferation in the majority of tumours. In contrast, the large tetraploid peak in normal liver represents mainly truly tetraploid G1 phase nuclei, as supported by the presence of a significant population in the octoploid area (tetraploid G2 and octoploid GI nuclei).
Unlike AAF, which blocks hepatocellular polyploidisation and thus expands the fraction of proliferating diploid hepatocytes Saeter et al., 1988b) , PB does not significantly change the hepatocellular ploidy distributions in normal (regenerated) liver . Some previous reports have even indicated that PB induces increased polyploidisation when stimulating the adult rat liver to grow (Staubli et al., 1969; Argyris, 1974) . The pronounced degree of diploidy seen in nearly all host liver tumours must therefore reflect a constitutive growth pattern which is not altered when tumour growth is stimulated by PB. PB would thus appear capable of stimulating polyploidising as well as non-polyploidising hepatocyte proliferation, the growth pattern being determined by the nature of the cells rather than by the promoter.
Hepatocellular polyploidisation is considered to be an irreversible process and a feature of cellular differentiation (Carriere, 1969; Brodsky & Uryvaeva, 1977) . Assuming that this irreversibility holds true also for cells involved in the hepatocarcinogenic process, only diploid precursor cells can give rise to diploid tumours. In our model of primary hepatocarcinogenesis, the fraction of diploid hepatocytes is increased (by AAF) 4-5 times above normal at the preneoplastic stages (Schwarze et al., 1984; Seglen et al., 1988a; Saeter et al., 1988b) . In DEN-initiated livers, the fraction of diploid hepatocytes remains significantly elevated even after AAF withdrawal, paralleling the retention of hepatocytes with elevated GGT levels . Some carcinogen-altered cells have thus come to express both phenotypic alterations in a constitutive manner. Subsequently developing neoplastic nodules and hepatocellular carcinomas are likewise predominantly diploid Seglen et al., 1988a) as well as GGTpositive (our unpublished results), suggesting the possibility of a precursor-product relationship.
The present study shows that following transplantation of preneoplastic cells generated in this model to a new liver environment in syngeneic hosts, the resulting tumours are still predominantly diploid (and GGT-positive), regardless of the ploidy composition of the donor cell suspension. Accordingly, it is reasonable to assume that it is the diploid, GGT-positive cells present in all donor suspensions that give rise ot the host liver tumours. In the few tumours with small aneuploid subpopulations, the majority (75-85%) of nuclei were nevertheless diploid (Figure 6 ), indicating that the aneuploid clones have been formed by derangement of an already established diploid-diploid proliferation pattern.
These results illustrate the fundamental and constitutive nature of the switch in hepatocellular proliferation from a normal polyploidising programme to a non-polyploidising diploid divisional programme, seen at all stages in our model of experimental hepatocarcinogenesis. The reports of similar findings in other models (Neal et al., 1976; Irving et al., 1977; Styles et al., 1985; Deleener et al., 1987) may well indicate that this is a general feature of liver carcinogenesis.
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